We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QIAGEN Receives FDA Clearance for JAK2 Diagnostic Test

News   Jan 24, 2018 | Original story from QIAGEN

 
QIAGEN Receives FDA Clearance for JAK2 Diagnostic Test
 
 
 

RELATED ARTICLES

Blood Test May Enable Tailored Cystic Fibrosis Treatment

News

Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis.

READ MORE

Saliva-based Alzheimer's Test Could be the Future

News

Three biomarkers for detecting mild cognitive impairment and Alzheimer’s disease in saliva samples have been identified.

READ MORE

Loss of Tight Junction Protein Promotes Development of Precancerous Cells

News

Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE